Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd - Class A

SHSE:688336 (China)   Class A
Â¥ 22.85 (+1.24%) May 27
39.40
P/B:
2.82
Market Cap:
Â¥ 14.09B ($ 1.95B)
Enterprise V:
Â¥ 12.45B ($ 1.72B)
Volume:
113.61M
Avg Vol (2M):
2.42M
Volume:
113.61M

Business Description

Description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
Name Current Vs Industry Vs History
Cash-To-Debt 30.33
Equity-to-Asset 0.93
Debt-to-Equity 0.01
Debt-to-EBITDA 0.13
Interest Coverage 228.26
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 21.39
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 14
3-Year Book Growth Rate 2.8
Name Current Vs Industry Vs History
5-Day RSI 37.38
9-Day RSI 42.16
14-Day RSI 45.82
6-1 Month Momentum % -1.51
12-1 Month Momentum % 29.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.38
Quick Ratio 6.66
Cash Ratio 5.01
Days Inventory 311.77
Days Sales Outstanding 44.06
Days Payable 33.99

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.36
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 1,073.589
EPS (TTM) (Â¥) 0.58
Beta 1.41
Volatility % 31.38
14-Day RSI 45.82
14-Day ATR (Â¥) 0.823323
20-Day SMA (Â¥) 23.7285
12-1 Month Momentum % 29.46
52-Week Range (Â¥) 16.02 - 26.78
Shares Outstanding (Mil) 616.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Frequently Asked Questions

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336)'s stock price today?
The current price of SHSE:688336 is ¥22.85. The 52 week high of SHSE:688336 is ¥26.78 and 52 week low is ¥16.02.
When is next earnings date of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336)?
The next earnings date of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) is .
Does Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) pay dividends? If so, how much?
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) does not pay dividend.

Press Release

Subject Date
No Press Release